First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 46, Issue 6, 2013, Pages 469-473

  Lee, Chia Jie ^a   Su, Lin Hui ^b,c   Huang, Yhu Chering ^a   Chiu, Cheng Hsun ^a,c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Ciprofloxacin resistance; International travel; Quinolone resistance determining regions; Salmonella enterica serovar Typhi

Indexed keywords

AMPICILLIN; CEFIXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ERTAPENEM; FLOMOXEF; IMIPENEM; PROTEIN PARC; QUINOLONE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CASE REPORT; CIPROFLOXACIN RESISTANT SALMONELLA TYPHI; CONTROLLED STUDY; DIARRHEA; FEMALE; FEVER; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC SIMILARITY; HUMAN; INDIA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SALMONELLA TYPHI; TAIWAN; TYPHOID FEVER;

CIPROFLOXACIN RESISTANCE; INTERNATIONAL TRAVEL; QUINOLONE RESISTANCE-DETERMINING REGIONS; SALMONELLA ENTERICA SEROVAR TYPHI;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; POINT MUTATION; POLYMERASE CHAIN REACTION; SALMONELLA TYPHI; SEQUENCE ANALYSIS, DNA; TAIWAN; TRAVEL; TYPHOID FEVER; YOUNG ADULT;

EID: 84890125389     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2013.01.002     Document Type: Article

References (28)

1. Crump J.A., Luby S.P., Mintz E.D. The global burden of typhoid fever. Bull World Health Organ 2004, 82:346-353.
2. Parry C.M., Hien T.T., Dougan G., White N.J., Farrar J.J. Typhoid fever. N Engl J Med 2002, 347:1770-1782.
3. Chitnis V., Chitnis D., Verma S., Hemvani N. Multidrug-resistant Salmonella typhi in India. Lancet 1999, 354:514-515.
4. Bhan M.K., Bahl R., Bhatnagar S. Typhoid and paratyphoid fever. Lancet 2005, 366:749-762.
5. Panigrahi D., Roy P., Sehgal R. Ciprofloxacin for typhoid fever. Lancet 1991, 338:1601.
6. Rowe B., Ward L.R., Threlfall E.J. Treatment of multiresistant typhoid fever. Lancet 1991, 337:1422.
7. Threlfall E.J., Ward L.R., Skinner J.A., Smith H.R., Lacey S. Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet 1999, 353:1590-1591.
8. Crump J.A., Barrett T.J., Nelson J.T., Angulo F.J. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for nonTyphi salmonellae. Clin Infect Dis 2003, 37:75-81.
9. Crump J.A., Kretsinger K., Gay K., Hoekstra R.M., Vugia D.J., Hurd S., et al. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study. Antimicrob Agents Chemother 2008, 52:1278-1284.
10. Brown J.C., Shanahan P.M., Jesudason M.V., Thomson C.J., Amyes S.G. Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India. J Antimicrob Chemother 1996, 37:891-900.
11. Lynch M.F., Blanton E.M., Bulens S., Polyak C., Vojdani J., Stevenson J., et al. Typhoid fever in the United States, 1999-2006. JAMA 2009, 302:859-865.
12. Medalla F., Sjolund-Karlsson M., Shin S., Harvey E., Joyce K., Theobald L., et al. Ciprofloxacin-resistant Salmonella enterica serotype Typhi, United States, 1999-2008. Emerg Infect Dis 2011, 17:1095-1098.
13. Threlfall E.J., Ward L.R. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom. Emerg Infect Dis 2001, 7:448-450.
14. Su C.P., Chen Y.C., Chang S.C. Changing characteristics of typhoid fever in Taiwan. J Microbiol Immunol Infect 2004, 37:109-114.
15. Grimont PAD, Weill FX. Antigenic formulae of the Salmonella serovars. 9th ed. World Health Organization Collaborating Centre for Reference and Research on Salmonella. Paris: Pasteur Institute; 2007.
16. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; 20th Informational Supplement. M100-S20. Wayne: Clinical and Laboratory Standards Institute; 2010.
17. Su L.H., Leu H.S., Chiu Y.P., Chia J.H., Kuo A.J., Sun C.F., et al. Molecular investigation of two clusters of hospital-acquired bacteraemia caused by multi-resistant Klebsiella pneumoniae using pulsed-field gel electrophoresis and in frequent restriction site PCR. J Hosp Infect 2000, 46:110-117.
18. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
19. Su L.H., Teng W.S., Chen C.L., Lee H.Y., Li H.C., Wu T.L., et al. Increasing ceftriaxone resistance in salmonellae, Taiwan. Emerg Infect Dis 2011, 17:1086-1090.
20. Chiu C.H., Su L.H., Chu C., Chia J.H., Wu T.L., Lin T.Y., et al. Isolation of Salmonella enterica serotype choleraesuis resistant to ceftriaxone and ciprofloxacin. Lancet 2004, 363:1285-1286.
21. Lee H.Y., Su L.H., Tsai M.H., Kim S.W., Chang H.H., Jung S.I., et al. High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia. Antimicrob Agents Chemother 2009, 53:2696-2699.
22. Gaind R., Paglietti B., Murgia M., Dawar R., Uzzau S., Cappuccinelli P., et al. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India. J Antimicrob Chemother 2006, 58:1139-1144.
23. Parry C., Wain J., Chinh N.T., Vinh H., Farrar J.J. Quinolone-resistant Salmonella typhi in Vietnam. Lancet 1998, 351:1289.
24. Murdoch D.A., Banatvaia N., Bone A., Shoismatulloev B.I., Ward L.R., Threlfall E.J. Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan. Lancet 1998, 351:339.
25. Ackers M.L., Puhr N.D., Tauxe R.V., Mintz E.D. Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise. JAMA 2000, 283:2668-2673.
26. Morita M., Hirose K., Takai N., Terajima J., Watanabe H., Sagara H., et al. Salmonella enterica serovar Typhi in Japan, 2001-2006: emergence of high-level fluoroquinolone-resistant strains. Epidemiol Infect 2010, 138:318-321.
27. Ochiai R.L., Acosta C.J., Danovaro-Holliday M.C., Baiqing D., Bhattacharya S.K., Agtini M.D., et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ 2008, 86:260-268.
28. Steinberg E.B., Bishop R., Haber P., Dempsey A.F., Hoekstra R.M., Nelson J.M., et al. Typhoid fever in travelers: who should be targeted for prevention?. Clin Infect Dis 2004, 39:186-191.